QR-Code

In-depth characterization of NK cell markers from CML patients who discontinued tyrosine kinase inhibitor therapy

IntroductionTreatment-free remission (TFR) in patients with chronic myeloid leukemia in chronic phase is considered a safe option if suitable molecular monitoring is available. However, the question arises as to which factors can contribute to the maintenance of TFR, and immunologic surveillance of...

Ausführliche Beschreibung

Gespeichert in:
Hauptverfasser: María Belén Sanchez, Bianca Vasconcelos Cordoba, Carolina Pavlovsky, Beatriz Moiraghi, Ana Varela, Rosario Custidiano, Isolda Fernandez, María Josefina Freitas, María Verónica Ventriglia, Georgina Bendek, Romina Mariano, María José Mela Osorio, Miguel Arturo Pavlovsky, Ana García de Labanca, Cecilia Foncuberta, Isabel Giere, Masiel Vera, Mariana Juni, José Mordoh, Julio Cesar Sanchez Avalos, Estrella Mariel Levy, Michele Bianchini
Format: Artigo
Sprache:Inglês
Veröffentlicht: Frontiers Media S.A. 2023-09-01
Schriftenreihe:Frontiers in Immunology
Schlagworte:
chronic myeloid leukemia
treatment free remission
NK cells
degranulation
immunophenotype
Online-Zugang:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1241600/full
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!

Ähnliche Einträge